About US
Contact us
-
Amgen, Teva hikes show pharma can't blame rebates for all price increases: analystPharma companies and pharmacy benefit managers have engaged in a back-and-forth for months over who’s to blame for high drug prices. Drugmakers say they're raising prices largely to keep ahead of PBMs2017/6/22
-
Lions Health versus mainstream Lions: are they really different breeds?ByRachel McCready, Klick Health; Creative Strategist Having just wrapped its fourth year, theCannes Lions Healthcompetition is still finding its identity. With the ever-expanding definition of health2017/6/21
-
With its €5.3B buyout scuppered, Stada brings in new CEO, CFOAfter failing to win the shareholder support needed to complete a €5.32 billion buyout, Stada is changing key executives. The company announced the resignations of CEO Matthias Wiedenfels and CFO Helm2017/6/18
-
Lilly’s Olumiant, spurned by FDA, gets nod from NICEEli Lilly has won a nod from NICE for its anticipated blockbuster and Humira competitor, Olumiant, a modicum of good news for a drug the FDA rejected in April. England’s cost watchdog, in final guida2017/6/17
-
Bayer stops production of Gynera contraceptive in BrazilBrazilian authorities, which earlier ordered drugmaker Bayer to pull its Essure birth control device from the market, have now asked for the recall of more than a dozen lots of a Bayer birth control p2017/6/16
-
As Congress battles over healthcare, Johnson & Johnson CEO says real reform will take time—and cooperationWhile Republican senators work feverishly on a healthcare bill, one prominent pharma CEO says overhauling the system won't take a few weeks of work. Think years, even decades—and he'd like Democrats t2017/6/15
-
Need proof that CV outcomes are make-or-break? See Merck's reaction to anacetrapib trial winFew thought Merck & Co.’s cholesterol-fighting candidate anacetrapib would hit its phase 3 trial goals. After all, three other drugs in the CETP inhibitor class failed dismally. But anacetrapib pu2017/6/14
-
FDA warning slams drugmaker that made teething tablets containing belladonnaAn FDA warning letter has slammed the New Jersey CMO that produced belladonna-treated teething products sold by CVS thatthe agency last year warnedmight cause hallucinations and seizures in infants.2017/6/14
-
Star-Tech & JRS Specialty Products Co., Ltd Chinese site receives EXCiPACT GMP certification as pharmaceutical excipient suppliersSTAR-TECH & JRS SPECIALTY PRODUCTS CO., LTD CHINESE SITE RECEIVESEXCiPACT GMP CERTIFICATION AS PHARMACEUTICAL EXCIPIENTSUPPLIERSBrussels, 08 June 2017EXCiPACT asbl is delighted to announce t2017/6/9
-
Synlogic completes first phase in ongoing R&D collaboration with AbbVieUS-based pharmaceutical firm Synlogic has met the first discovery milestone in its ongoing research and development (R&D) collaboration with AbbVie. In the completed first discovery phase, Synlog2017/6/9